Zevra Therapeutics (ZVRA) Current Taxes (2025 - 2026)
Zevra Therapeutics (ZVRA) reported Current Taxes of $20.4 million for Q1 2026, up 48.46% quarter-over-quarter from $13.7 million in Q4 2025.
Zevra Therapeutics (ZVRA) Current Taxes (2025 - 2026) Analysis & Trends
Zevra Therapeutics has reported Current Taxes for 2 years, with the latest figure at $20.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes changed N/A year-over-year to $20.4 million; the trailing twelve-month figure through Mar 2026 stood at $20.4 million (changed N/A YoY), and the FY2025 full-year result was $13.7 million, changed N/A from the prior year.
- Current Taxes for Q1 2026 stood at $20.4 million, up from $13.7 million in the prior quarter.
- The five-year high for Current Taxes was $20.4 million in Q1 2026, with the low at $13.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 10,460.56 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Zevra Therapeutics | 796.95 Mn | 596.33 Mn | 34.30 Mn | 20.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.35 Mn |
| Dec 31, 2025 | 13.71 Mn |